Investors who lost money on SeaStar Medical Holding Corporation (ICU) should contact Levi & Korsinsky about pending Class Action - ICU

Core Viewpoint - A class action securities lawsuit has been filed against SeaStar Medical Holding Corporation, alleging securities fraud that affected investors between October 31, 2022, and March 26, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that SeaStar Medical and Legacy SeaStar had inadequate compliance controls related to the Humanitarian Device Exemption (HDE) Application [2]. - It is alleged that the FDA was unlikely to approve the HDE Application in its current form, and the regulatory prospects of the selective cytopheretic device were overstated [2]. - The company is accused of downplaying the severity of deficiencies in its financial controls while overstating efforts to remediate these issues [2]. - SeaStar allegedly failed to properly account for the classification of certain outstanding warrants and a prepaid forward agreement [2]. - The lawsuit suggests that SeaStar may need to restate one or more previously issued financial statements [2]. - As a result of these issues, the company's public statements were claimed to be materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until September 6, 2024, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing significant compensation for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4].